$1.50
-0.15-9.09%
At close: -
$1.51
0.010.67%
After Hours: 6:47 PM EDT
Actinium Pharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Actinium Pharma using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-05 | $-0.38 | $-0.40 | 5.00 % |
Mar 2024 | 2024-04-26 | $-0.31 | $-0.52 | 40.4 % |
Dec 2023 | 2024-03-29 | $-0.33 | $-0.54 | 38.9 % |
Sep 2023 | 2023-11-02 | $-0.49 | $-0.51 | 3.92 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2023 | 2023-11-02 | $0 | $570.00K | -100.0 % |
Mar 2023 | 2023-04-03 | $0 | $1.03M | -100.0 % |
Actinium Pharma (ATNM) is scheduled to report earnings on November 29, 2024. The last reported earnings were for reported on August 5, 2024 for Q2.
The Actual EPS was $-0.38, which beat the estimate of $-0.40.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.